Intermittent preventive treatment for malaria in sub-Saharan African: A halfway technology or a critical intervention?

American Journal of Tropical Medicine and Hygiene

Volumn 82, Issue 5, 2010, Pages 755-756

  Vinetz, Joseph M ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; FANSIDAR; MALARIA VACCINE; PYRIMETHAMINE;

AFRICA; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; GENE MUTATION; HEALTH CARE POLICY; HUMAN; MALARIA; MALARIA CONTROL; META ANALYSIS; PLASMODIUM FALCIPARUM; POVERTY; PRENATAL CARE; PREVENTIVE HEALTH SERVICE; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW;

ADULT; AFRICA SOUTH OF THE SAHARA; ANTIMALARIALS; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALARIA; PREGNANCY;

EID: 77952707316     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2010.825editorial     Document Type: Editorial

References (11)

1. Thomas L, 1971. The technology of medicine. N Engl J Med 285: 1366-1368.
2. Thomas L, 1974. The Lives of a Cell. New York: Penguin Books.
3. Grobusch MP, Egan A, Gosling RD, Newman RD, 2007. Intermittent preventive therapy for malaria: progress and future directions. Curr Opin Infect Dis 20:613-620. (Pubitemid 350059521)
4. Raman J, Little F, Roper C, Kleinschmidt I, Cassant Y, Maharaj R, Barnes KI, 2010. Five years of large-scale dhfr and dhps mutation surveillance following the phased implementation of artesunate plus sulfadoxine-pyrimethamine in Maputo province, southern Mozambique. Am J Trop Med Hyg 82:788-794.
5. Aponte JJ, Schellenberg D, Egan A, Breckenridge A, Carneiro I, Critchley J, Danquah I, Dodoo A, Kobbe R, Lell B, May J, Premji Z, Sanz S, Sevene E, Soulaymani-Becheikh R, Winstanley P, Adjei S, Anemana S, Chandramohan D, Issifou S, Mockenhaupt F, Owusu-Agyei S, Greenwood B, Grobusch MP, Kremsner PG, Macete E, Mshinda H, Newman RD, Slutsker L, Tanner M, Alonso P, Menendez C, 2009. Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials. Lancet 374: 1533-1542.
6. Gosling RD, Gesase S, Mosha JF, Carneiro I, Hashim R, Lemnge M, Mosha FW, Greenwood B, Chandramohan D, 2009. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial. Lancet 374: 1521-1532.
7. O'Meara WP, Smith DL, McKenzie FE, 2006. Potential impact of intermittent preventive treatment (IPT) on spread of drug-resistant malaria. PLoS Med 3: e141.
8. White NJ, 2005. Intermittent presumptive treatment for malaria. PLoS Med 2: e3.
9. de Sousa A, Salama P, Chopra M, 2010. Implementing intermittent preventive treatment in infants. Lancet 375:121.
10. McGready R, 2009. Intermittent preventive treatment of malaria in infancy. Lancet 374:1478-1480.
11. Laufer MK, Thesing PC, Eddington ND, Masonga R, Dzinjalamala FK, Takala SL, Taylor TE, Plowe CV, 2006. Return of chloroquine antimalarial efficacy in Malawi. N Engl J Med 355:1959-1966. (Pubitemid 44708015)